23 Jul, 2026
According to Straits Research, the global electrotherapy market size was valued at $1,331.67 million in 2025 and is projected to grow from $1,400.92 million in 2026 to $2,101.55 million by 2034 at a CAGR of 5.2% during the forecast period 2026-2034.
The use of electric impulses to relax muscles, improve blood flow, repair tissues, and encourage bone formation is known as electrotherapy. Global demand for electrotherapy has increased as a result of the use of physiotherapy in the treatment of various ailments. Electrotherapy is the application of electrical impulses to relax muscles, enhance blood flow, heal tissues, and promote bone growth.
Technological advancements in interferential therapy, ultrasound therapy, and transcutaneous electrical nerve stimulation are anticipated to support market growth. Recent product innovations from manufacturers allow us to see how far technology has come. For instance, in February 2021, KT Tape LLC (US) unveiled the newest addition to its recovery product line, KT Recovery+ Wave. The KT Wave, the powerful electromagnetic technology previously only available at a doctor's office, is transformed into a wearable, convenient solution by the FDA-approved wearable device KT Wave. It provides drug-free relief for sprains, arthritis, back pain, carpal tunnel syndrome, sports injuries, knee pain, and other symptoms. The increasing number of product launches and strategic moves made by manufacturers in the global electrotherapy market are expected to speed up market growth.
New products that can help patients in various ways, including pain relief, have also been developed as electrotherapy technology advances. According to data from the US Bureau of Economic Analysis, domestic production of medical supplies and equipment is increasing in real output and value-added (BEA). The larger "Medical Equipment and Supplies Manufacturing" industry had USD 102 billion in gross output and USD 62 billion in value added in 2018. This includes the two most essential subcategories, "Surgical and Medical Instrument Manufacturing" (USD 45.9 billion) and "Surgical Appliance and Supplies Manufacturing" (USD 37.4 billion). The latter category, which includes ventilators, masks, and numerous other essential medical supplies, saw an increase in real output of nearly 90% during the period under consideration. Manufacturing of analytical laboratory instruments (121.8%), irradiation apparatus (468.0%), and electromedical and electrotherapeutic apparatus (418.1%) were among the sectors that experienced notable increases in real output.
Americas is the most significant shareholder in the global electrotherapy market and is expected to grow at a CAGR of 5.53% during the forecast period. The developed healthcare system, growing demand for electrotherapy, and the existence of significant regional players are all factors in the Americas' 40.44% market share. Another aspect of the market's growth in the region is the high rate of sports-related injuries. For instance, according to estimates from the Centers for Disease Control and Prevention (CDC), 273,272 children (age 17 or younger) were treated in emergency departments (EDs) in the US in 2016 for nonfatal traumatic brain injuries (TBIs) related to sports and recreation. It is estimated that 3.5 million children suffer injuries from sports-related incidents annually. Bicycling was the second riskiest sport, with about 417,000 injuries, while football and basketball were third and fourth, with 404,000 and 292,000 injuries, respectively. In addition, the increasing use of electrotherapy systems in treating sports injuries among professional athletes and sportsmen is thus another factor driving the market in North America.
Europe is expected to grow at a CAGR of 4.43% during the forecast period. The rise in diabetes prevalence and the resulting increase in diabetic nerve pain are blamed for the market expansion. According to the World Health Organization, there are about 60 million diabetics in Europe (WHO). Diabetes is increasing in prevalence among people of all ages in the European region, primarily due to increased overweight and obesity, a poor diet, and sedentary lifestyles. In addition, the region's steadily rising cancer survivability rate and expanding geriatric population are also anticipated to contribute to the electrotherapy market's expansion. High healthcare spending is also expected to fuel the market's growth. According to a report released by the European Union, approximately 9.6% of the entire gross domestic product was spent on healthcare in European nations.
sales@straitsresearch.com